|
⚲
|
| Keyboard |
| Gayer Charles K
✚
|
|
|---|---|
| CIK # | 0001800110 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001800110] | |
| 4 | [0001800110] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gayer Charles K | |
| Biocryst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2025-12-22 | Option exercise | 50,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-22 | Option exercise | 50,000 | $5.51 | 275,500 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-22 | Option exercise | 14,142 | $3.22 | 45,537 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2025-12-22 | Option exercise | 14,142 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-22 | Option exercise | 10,091 | $5.04 | 50,859 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2025-12-22 | Option exercise | 10,091 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-19 | Tax withheld | 11,477 | $7.41 | 85,045 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2025-12-17 | Grant | 986,950 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-17 | Grant | 471,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-12 | Tax withheld | 8,181 | $7.57 | 61,930 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2024-12-19 | Grant | 260,950 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-19 | Grant | 125,950 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-19 | Tax withheld | 2,461 | $7.39 | 18,187 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-14 | Tax withheld | 8,251 | $7.53 | 62,130 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-05-13 | Buy | 30,000 | $5.47 | 164,100 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-19 | Tax withheld | 2,482 | $6.05 | 15,016 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-14 | Grant | 34,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-14 | Tax withheld | 5,840 | $6.43 | 37,551 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2023-12-14 | Grant | 158,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2022-12-19 | Grant | 34,000 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||